Tempest Therapeutics, Inc. (TPST) Shareholders’ equity 2016–2017
Tempest Therapeutics, Inc. (TPST) shareholders’ equity at each fiscal year-end, per SEC filings.
-$130.7MFY2017 · since FY2016: $108.2M → -$130.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2017 | -$130.7M | -220.8% |
| FY2016 | $108.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice